COLUMBIA, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MEDSTAR HEALTH RESEARCH INSTITUTE INC, founded in 1963, is a mid-sized nonprofit that reported $74.1M in total revenue in fiscal year 2024. Revenue surged 25% from the prior year, signaling strong growth momentum.
MEDSTAR HEALTH RESEARCH INSTITUTE (THE RESEARCH INSTITUTE) IS THE RESEARCH ARM FOR MEDSTAR HEALTH, PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND REGULATORY SUPPORT FOR RESEARCH PROGRAMS THAT COMPLEMENT THE KEY CLINICAL SERVICES AND TEACHING PROGRAMS IN ALL HOSPITALS IN THE SYSTEM. THE RESEARCH INSTITUTE SUPPORTS CLINICAL RESEARCH PERFORMED BY ATTENDING MEDICAL STAFF, AND FULL-TIME RESEARCH INVESTIGATORS. THE RESEARCH INSTITUTE AND ITS INVESTIGATORS PROVIDE PATIENTS ACCESS TO THE LATEST CLINICAL TRIALS, CUTTING-EDGE DIAGNOSTICS, AND INNOVATIVE THERAPIES WHILE DISCOVERING NEW WAYS TO TREAT PEOPLE THROUGH HEALTH SERVICES AND CLINICAL RESEARCH. WITH MORE THAN 1,000 ACTIVE RESEARCH STUDIES AND CLINICAL TRIALS CONDUCTED ACROSS 40 DIFFERENT CARE SITES AND OVER 900 PEER-REVIEWED PUBLICATIONS IN FISCAL YEAR 2025, THE RESEARCH INSTITUTE'S PORTFOLIO INCLUDES CLINICAL AND INVESTIGATIVE WORK ACROSS CLINICAL SERVICE LINES INCLUDING CARDIOVASCULAR, ONCOLOGY, DIABETES, ORTHOPAEDICS, NEUROLOGY, GASTROENTEROLOGY, REHABILITATION, CRITICAL CARE, WOMEN'S HEALTH, HEALTHCARE QUALITY AND PATIENT SAFETY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $74,089,762 | $59,461,537 | +0.2% |
| Expenses | $78,357,235 | $69,535,678 | +0.1% |
| Net Income | $-4,267,473 | $-10,074,141 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SOO Y BANG MSHA | DIRECTOR (UNTIL 10/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| EDWARD B HEALTON MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NORMAN J BEAUCHAMP JR MD | DIRECTOR (AS OF 9/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| DALE MCELVEEN | DIRECTOR (AS OF 9/2024) | 1.00 |
Director
|
$0 | $0 | $0 |
| DEREK GRIFFITH PHD | DIRECTOR (UNTIL 1/2025) | 1.00 |
Director
|
$0 | $0 | $0 |
| SPIROS DIMOLITSAS PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN RT EVANS MD | DIRECTOR | 1.00 |
Director
|
$0 | $66,390 | $3,091,812 |
| SARAH GREENE MPH | CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| PRENTICE PARRISH | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANAND SHAH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN SMITH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| FRED BUTLER JR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY B LEE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN M YOUNG PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PAMELA TENAERTS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| TAMIKA AUGUSTE MD | DIRECTOR | 1.00 |
Director
|
$0 | $34,051 | $757,499 |
| NEIL J WEISSMAN MD | PRESIDENT/DIRECTOR | 40.00 |
Officer
Director
|
$1,185,542 | $62,330 | $1,247,872 |
| WILLIAM GAYNE | TREASURER (UNTIL 8/2024) | 20.00 |
Officer
|
$188,029 | $31,059 | $407,117 |
| KEITH SHINER | SECRETARY | 1.00 |
Officer
|
$0 | $34,699 | $356,263 |
| AMANDA BARASH | TREASURER (AS OF 11/2024) | 20.00 |
Officer
|
$14,151 | $22 | $28,324 |
| STEPHAN QUIRICONI | INTERIM TREASURER (08/2024-11/2024) | 20.00 |
Officer
|
$56,586 | $0 | $113,172 |
| FEDERICO ASCH MD | SCIENTIFIC DIRECTOR | 40.00 |
Highest
|
$600,912 | $27,669 | $628,581 |
| RAJ RATWANI PHD | VP SCIENTIFIC AFFAIRS | 40.00 |
Highest
|
$441,548 | $19,999 | $461,547 |
| SETH KREVAT MD | MEDICAL DOCTOR | 40.00 |
Highest
|
$374,309 | $21,094 | $395,403 |
| WILLIAM WEINTRAUB | PHYSICIAN INVESTIGATOR | 40.00 |
Highest
|
$381,146 | $28,408 | $409,554 |
| SUZANNE SIMKOVICH | PHYSICIAN INVESTIGATOR | 40.00 |
Highest
|
$455,976 | $30,550 | $486,526 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $74,089,762 | $78,357,235 | $46,768,247 | $-4,267,473 |
| 2024 | No data | No data | No data | No data |
| 2023 | $52,774,409 | $63,252,010 | $40,740,989 | $-10,477,601 |
| 2022 | $50,039,397 | $58,646,314 | $46,788,307 | $-8,606,917 |
| 2021 | $47,234,985 | $52,955,266 | $50,666,334 | $-5,720,281 |
| 2020 | $39,716,879 | $44,791,996 | $57,300,150 | $-5,075,117 |
| 2019 | $36,064,856 | $44,800,868 | $23,488,796 | $-8,736,012 |
| 2018 | $33,191,605 | $40,877,231 | $21,596,713 | $-7,685,626 |
Compare MEDSTAR HEALTH RESEARCH INSTITUTE INC with other nonprofits in Maryland and across the country.